Stock Updates

Is this Large Market Cap Stock target price reasonable for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)?

The company in question is, Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) currently with a stock price of 102.25 (-0.18% today). The market cap for Vertex Pharmaceuticals Incorporated is 25091.25, and is in the sector Healthcare, and Biotechnology industry. The target price for Vertex Pharmaceuticals Incorporated is 110.32. Currently Vertex Pharmaceuticals Incorporated is trading with a P/E of *TBA, and a forward P/E of 32.91. Average volume for Vertex Pharmaceuticals Incorporated is 1551.2 and so far today it is 502408.

Performance in the last year for Vertex Pharmaceuticals Incorporated has been -26.54%. For EPS growth, Vertex Pharmaceuticals Incorporated has seen a growth of 26.50%, and is looking to grow in the next year to 204.50%. More long term stats show that EPS growth has been 9.30% over the last five years and could be 53.27% for the next five years. Vertex Pharmaceuticals Incorporated has seen sales growth quarter over quarter at 159.80%, with EPS growth quarter over quarter at 66.40%. The 20-day simple moving average is 12.07%, with the 200-day simple moving average coming to 4.71%.

Since the IPO date for Vertex Pharmaceuticals Incorporated on the 7/24/1991, Vertex Pharmaceuticals Incorporated has seen performance year to date to be -18.60%. With Vertex Pharmaceuticals Incorporated trading at 102.25, the dividend yield is *TBA, and the EPS is -1.13.

So could Vertex Pharmaceuticals Incorporated, be undervalued? Well as said before P/E is *TBA. The PEG is *TBA, P/S is 16.11 and the P/B is at 25.54. The P/cash is 23.42, with P/free cash flow at 92.93.

Vertex Pharmaceuticals Incorporated ability to deal with debt shows that the current ratio is 2.3, and the quick ratio is 2.2. This is with long term debt/equity at 0.59, and total debt/equity at 0.84.

In terms of margins, Vertex Pharmaceuticals Incorporated has a gross margin of 88.00%, an operating margin of -8.70% and a profit margin of -17.70%.Payout ratio for Vertex Pharmaceuticals Incorporated is *TBA. Return on assets come to -11.00% with return on investment coming to -28.20%.

Insider ownership for Vertex Pharmaceuticals Incorporated, is at 0.40% and institutional ownership comes to 96.80%. Outstanding shares are at 244.96. While shares float is 244.96. The float short is currently 2.34%, and short ratio is 3.69.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Mark Hines

Leave a Comment